SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC)
CTIC 9.0900.0%Jun 26 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WHL who wrote (24)3/27/1998 4:24:00 PM
From: dipper  Read Replies (1) of 946
 
In factoring the cash position, you must also subtract the cash burned this quarter.(ending 3/31/98). The math:

74 million in cash (includes the $2.9 milliom) receivable on the books as of years end) less roughly $7 million in cash burned (8.1 million estimate for Q1, plus roughly $1 million in deprciation is the calculation) equals $67 million in cash divided by 14.8 million shares = roughly $4.52 per share in cash.

Never, have I seen a bio-tech trade below cash. With the completely unexpected news of no endpoints reached, this is what, I believe, oversold the stock to below cash. Also, take note of all the insider buys in the past 45 days. This dog will bounce soon, the only question left is how high? Any opinions out there?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext